Chargement en cours...
Gene dysregulation analysis builds a mechanistic signature for prognosis and therapeutic benefit in colorectal cancer
The implementation of cancer precision medicine requires biomarkers or signatures for predicting prognosis and therapeutic benefits. Most of current efforts in this field are paying much more attention to predictive accuracy than to molecular mechanistic interpretability. Mechanism-driven strategy h...
Enregistré dans:
| Publié dans: | J Mol Cell Biol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883816/ https://ncbi.nlm.nih.gov/pubmed/32717065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjaa041 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|